Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer (SetPace)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
USHIFU, LLC
ClinicalTrials.gov Identifier:
NCT00770822
First received: October 9, 2008
Last updated: December 9, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2013
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)